Recall of Anti-ADENOVIRUS GROUPE (except ADV-8) / clone BIO-11

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by ARGENE BIOSOFT.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2003-01-16
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    ARGENE BIOSOFT withdraws from the market the batch G2206 (per 06.03) of the in vitro diagnostic medical device called Anti-ADENOVIRUS GROUPE (except ADV-8) / clone BIO-11 / references 11-021 and 14-021, following the detection of a decrease of sensitivity with respect to types 2 and 12 of Adenovirus. This device is used for the detection of Adenoviruses in infected cells obtained from samples of secretions and cells of the respiratory tracts or after isolation on cell cultures ...

Device

  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer

Manufacturer

  • Source
    LAANSM